Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Adams A. et al, (2022), Gut
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
McGregor CG. et al, (2021), Gut, 70, 2398 - 2400
Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease
Kalla R. et al, (2020), Journal of Crohn's and Colitis, 14, 1724 - 1733
Blood-based DNA methylation in Crohn's disease and severity of intestinal inflammation.
Kalla R. et al, (2019), Translational gastroenterology and hepatology, 4
Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome.
Olbjørn C. et al, (2019), Clinical and experimental gastroenterology, 12, 37 - 49
Purine metabolism controls innate lymphoid cell function and protects against intestinal injury
Crittenden S. et al, (2018), Immunology and Cell Biology, 96, 1049 - 1059
Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD
Adams A. et al, (2018), Alimentary Pharmacology & Therapeutics, 47, 306 - 307
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
Ventham NT. et al, (2016), Nature Communications, 7
Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases
Kalla R. et al, (2016), American Journal of Gastroenterology, 111, 1796 - 1805
Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohnʼs Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci
Adams AT. et al, (2014), Inflammatory Bowel Diseases, 20, 1784 - 1793